Potential role of serum and urinary biomarkers in diagnosis and prognosis of diabetic nephropathy

CG Campion, O Sanchez-Ferras… - Canadian journal of …, 2017 - journals.sagepub.com
Purpose of review: Diabetic nephropathy (DN) is a progressive kidney disease caused by
alterations in kidney architecture and function, and constitutes one of the leading causes of …

Urinary biomarkers in the assessment of early diabetic nephropathy

C Gluhovschi, G Gluhovschi, L Petrica… - Journal of diabetes …, 2016 - Wiley Online Library
Diabetic nephropathy (DN) is a frequent and severe complication of diabetes mellitus (DM).
Its diagnosis in incipient stages may allow prompt interventions and an improved prognosis …

Cardio-renal syndromes: report from the consensus conference of the acute dialysis quality initiative

C Ronco, P McCullough, SD Anker, I Anand… - European heart …, 2010 - academic.oup.com
A consensus conference on cardio-renal syndromes (CRS) was held in Venice Italy, in
September 2008 under the auspices of the Acute Dialysis Quality Initiative (ADQI). The …

Glomerular and tubular damage markers are elevated in patients with diabetes

FL Nauta, WE Boertien, SJL Bakker, H Van Goor… - Diabetes …, 2011 - Am Diabetes Assoc
OBJECTIVE We investigated in a cross-sectional study the levels of serum and urinary
damage markers in diabetic patients (n= 94) and nondiabetic control subjects (n= 45) to …

Cystatin C as an early biomarker of nephropathy in patients with type 2 diabetes

YK Jeon, MR Kim, JE Huh, JY Mok… - Journal of Korean …, 2011 - synapse.koreamed.org
This study was done to evaluate clinical usefulness of cystatin C levels of serum and urine in
predicting renal impairment in normoalbuminuric patients with type 2 diabetes and to …

Tubular damage in chronic systolic heart failure is associated with reduced survival independent of glomerular filtration rate

K Damman, DJ Van Veldhuisen, G Navis, VS Vaidya… - Heart, 2010 - heart.bmj.com
Background The prognostic impact of reduced glomerular filtration rate (GFR) in chronic
heart failure (CHF) is increasingly recognised, but little is known about tubular damage in …

[HTML][HTML] Biomarkers in diabetic nephropathy: present and future

G Currie, G McKay, C Delles - World journal of Diabetes, 2014 - ncbi.nlm.nih.gov
Diabetic nephropathy (DN) is the leading cause of end stage renal disease in the Western
world. Microalbuminuria (MA) is the earliest and most commonly used clinical index of DN …

Urinary markers of tubular injury in early diabetic nephropathy

T Fiseha, Z Tamir - International journal of nephrology, 2016 - Wiley Online Library
Diabetic nephropathy (DN) is a common and serious complication of diabetes associated
with adverse outcomes of renal failure, cardiovascular disease, and premature mortality …

Diabetic nephropathy: traditional to proteomic markers

RN Moresco, MB Sangoi, JAM De Carvalho, E Tatsch… - Clinica chimica acta, 2013 - Elsevier
Diabetic nephropathy (DN) is one of the major microvascular complications of diabetes and
it is defined as a rise in the urinary albumin excretion (UAE) rate and abnormal renal …

Urinary biomarkers for early diabetic nephropathy in type 2 diabetic patients

T Fiseha - Biomarker research, 2015 - Springer
Diabetic nephropathy (DN) is a serious complication of diabetes associated with increased
risk of mortality, and cardiovascular and renal outcomes. Diagnostic markers to detect DN at …